JP2023542737A5 - - Google Patents
Info
- Publication number
- JP2023542737A5 JP2023542737A5 JP2023519633A JP2023519633A JP2023542737A5 JP 2023542737 A5 JP2023542737 A5 JP 2023542737A5 JP 2023519633 A JP2023519633 A JP 2023519633A JP 2023519633 A JP2023519633 A JP 2023519633A JP 2023542737 A5 JP2023542737 A5 JP 2023542737A5
- Authority
- JP
- Japan
- Prior art keywords
- igg
- substitution
- amino acid
- modified
- modified igg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063084693P | 2020-09-29 | 2020-09-29 | |
| US63/084,693 | 2020-09-29 | ||
| PCT/US2021/052579 WO2022072446A1 (en) | 2020-09-29 | 2021-09-29 | Feline antibody variants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023542737A JP2023542737A (ja) | 2023-10-11 |
| JP2023542737A5 true JP2023542737A5 (https=) | 2024-10-02 |
Family
ID=78599139
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023519633A Pending JP2023542737A (ja) | 2020-09-29 | 2021-09-29 | ネコ科動物抗体バリアント |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US12612455B2 (https=) |
| EP (2) | EP4221744A1 (https=) |
| JP (1) | JP2023542737A (https=) |
| KR (1) | KR20230091914A (https=) |
| CN (1) | CN116457369A (https=) |
| AR (1) | AR123645A1 (https=) |
| AU (1) | AU2021352395A1 (https=) |
| CA (1) | CA3195049A1 (https=) |
| CL (2) | CL2023000914A1 (https=) |
| CO (1) | CO2023004107A2 (https=) |
| EC (1) | ECSP23030307A (https=) |
| IL (1) | IL301414A (https=) |
| MX (1) | MX2023003694A (https=) |
| PE (1) | PE20240110A1 (https=) |
| TW (3) | TWI814094B (https=) |
| WO (1) | WO2022072446A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022072446A1 (en) | 2020-09-29 | 2022-04-07 | Zoetis Services Llc | Feline antibody variants |
| WO2025166165A1 (en) * | 2024-02-01 | 2025-08-07 | Zoetis Services, Llc | Compositions and methods for modifying antibody effector functions |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6284471B1 (en) | 1991-03-18 | 2001-09-04 | New York University Medical Center | Anti-TNFa antibodies and assays employing anti-TNFa antibodies |
| US5698762A (en) | 1994-12-09 | 1997-12-16 | Dauerman; Leonard | Microwave-assisted pyrolysis of waste polyaromatic hydrocarbons |
| GB9601081D0 (en) * | 1995-10-06 | 1996-03-20 | Cambridge Antibody Tech | Specific binding members for human transforming growth factor beta;materials and methods |
| US20030031671A1 (en) | 2001-08-01 | 2003-02-13 | Sydney Welt | Methods of treating colon cancer utilizing tumor-specific antibodies |
| EP1740615B1 (en) | 2004-03-31 | 2014-11-05 | Genentech, Inc. | Humanized anti-tgf-beta antibodies |
| AU2005285347A1 (en) | 2004-08-19 | 2006-03-23 | Genentech, Inc. | Polypeptide variants with altered effector function |
| US8546543B2 (en) | 2004-11-12 | 2013-10-01 | Xencor, Inc. | Fc variants that extend antibody half-life |
| AU2005304624B2 (en) | 2004-11-12 | 2010-10-07 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| HRP20150279T1 (hr) * | 2007-12-26 | 2015-05-08 | Xencor, Inc. | Fc inaäśice s promijenjenim vezanjem na fcrn |
| WO2012024650A2 (en) | 2010-08-19 | 2012-02-23 | Abbott Laboratories | Anti-ngf antibodies and their use |
| US8790651B2 (en) | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| CA2875783C (en) | 2012-06-06 | 2018-12-11 | Zoetis Llc | Caninized anti-ngf antibodies and methods thereof |
| WO2019113123A1 (en) * | 2017-12-04 | 2019-06-13 | Precithera, Inc. | TGF-ß RECEPTOR FUSION PROTEINS AND OTHER TGF-ß ANTAGONISTS FOR REDUCING TGF-ß SIGNALING |
| US20210388053A1 (en) | 2018-10-18 | 2021-12-16 | Kindred Biosciences, Inc. | Fc Variants with Altered Binding to Neonatal Fc Receptor (FCRN) for Veterinary Use |
| JP7536294B2 (ja) * | 2018-12-05 | 2024-08-20 | 株式会社バイカ・セラピュティクス | 抗体のＦｃ領域改変体 |
| MX2022012793A (es) | 2020-04-17 | 2022-11-07 | Zoetis Services Llc | Variantes de anticuerpos felinos. |
| WO2022072446A1 (en) | 2020-09-29 | 2022-04-07 | Zoetis Services Llc | Feline antibody variants |
| KR20230121056A (ko) | 2020-12-18 | 2023-08-17 | 조에티스 서비시즈 엘엘씨 | 고양이 항체 불변 영역의 돌연변이 |
-
2021
- 2021-09-29 WO PCT/US2021/052579 patent/WO2022072446A1/en not_active Ceased
- 2021-09-29 AR ARP210102710A patent/AR123645A1/es unknown
- 2021-09-29 AU AU2021352395A patent/AU2021352395A1/en active Pending
- 2021-09-29 CA CA3195049A patent/CA3195049A1/en active Pending
- 2021-09-29 TW TW110136252A patent/TWI814094B/zh active
- 2021-09-29 PE PE2023001243A patent/PE20240110A1/es unknown
- 2021-09-29 US US18/246,725 patent/US12612455B2/en active Active
- 2021-09-29 TW TW114113296A patent/TW202545990A/zh unknown
- 2021-09-29 KR KR1020237014648A patent/KR20230091914A/ko active Pending
- 2021-09-29 EP EP21806456.6A patent/EP4221744A1/en not_active Withdrawn
- 2021-09-29 TW TW112132477A patent/TWI880316B/zh active
- 2021-09-29 MX MX2023003694A patent/MX2023003694A/es unknown
- 2021-09-29 EP EP25199779.7A patent/EP4711383A3/en active Pending
- 2021-09-29 JP JP2023519633A patent/JP2023542737A/ja active Pending
- 2021-09-29 IL IL301414A patent/IL301414A/en unknown
- 2021-09-29 CN CN202180077397.2A patent/CN116457369A/zh active Pending
-
2023
- 2023-03-29 CO CONC2023/0004107A patent/CO2023004107A2/es unknown
- 2023-03-29 CL CL2023000914A patent/CL2023000914A1/es unknown
- 2023-04-25 EC ECSENADI202330307A patent/ECSP23030307A/es unknown
-
2024
- 2024-03-18 CL CL2024000789A patent/CL2024000789A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023522030A5 (https=) | ||
| CN110382529B (zh) | 工程化的异源二聚体蛋白质 | |
| JP2023522029A5 (https=) | ||
| CN110520445B (zh) | 抗pd-l1/抗pd-1天然抗体结构样异源二聚体形式双特异抗体及其制备 | |
| TWI585104B (zh) | 基於vl和vhh可變區衍生物的高親和力抗聚集抗體 | |
| JP2021530236A5 (https=) | ||
| JP2020519643A5 (https=) | ||
| JP7339948B2 (ja) | モノクローナル抗体およびその使用法 | |
| JP2020515518A5 (https=) | ||
| JP2022512043A5 (https=) | ||
| RU2712251C1 (ru) | Гуманизированные антитела против участка бета цепи 9-го семейства TRBV9 TKP человека, и способы их применения | |
| JP2020505017A5 (https=) | ||
| IL276286B1 (en) | FC variants with improved binding to FCRN and extended half-life | |
| JP2023543262A5 (https=) | ||
| WO2022206900A1 (zh) | 抗人血清白蛋白(hsa)的纳米抗体及其应用 | |
| JP2020500510A5 (https=) | ||
| JP2022009816A5 (https=) | ||
| JP2023542737A5 (https=) | ||
| JP2018148915A5 (https=) | ||
| US20230212321A1 (en) | Methods and means for the production of ig-like molecules | |
| JP2020519562A (ja) | 抗インターフェロンガンマ抗体およびその使用法 | |
| CN102892885A (zh) | IgA结合性肽以及利用其的IgA的纯化 | |
| JP2022546002A (ja) | ４価の対称型二重特異性抗体 | |
| JP2021506310A5 (https=) | ||
| TW201904998A (zh) | 不對稱異二聚fc-scfv融合抗globo h及抗cd3雙特異性抗體及其於癌症治療上之用途 |